• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

DOI: 10.12201/bmr.202504.00050
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Objective This study aims to retrospectively analyze the clinical data of patients with thyroid cancer combined with primary hyperparathyroidism at Beijing Friendship Hospital. The objective is to explore the disease characteristics, diagnostic processes, and surgical treatment strategies for these patients. Through this analysis, the study seeks to enhance surgeons understanding of this condition and provide scientific evidence for developing more precise and effective treatment plans, ultimately improving patient outcomes.Methods Retrospective case analysis was performed on patients with thyroid cancer complicated with primary hyperparathyroidism who underwent surgical treatment from January 2016 to January 2022 in our hospital, and some thyroid cancer patients were randomly selected as the control group. The operation time, blood loss, hospital stay, and complications were compared between the two groupsResults A total of 3686 patients with thyroid cancer were included in the study, including 22 patients with primary hyperparathyroidism.44 thyroid cancer patients were randomly selected as the control group. There was no statistical difference in the preoperative basic line such as the age, gender, BMI and the diameter of thyroid cancer. Both groups underwent surgery, and the thyroid cancer patients with primary hyperparathyroidism group had a longer operation time than the thyroid cancer patient group (p<0.0001), but there was no statistical difference in intraoperative blood loss, hospital stay, and postoperative complications.Conclusion The coexistence of thyroid cancer with primary hyperparathyroidism (PHPT) increases the complexity of treatment. However, with thorough preoperative diagnosis and well-planned surgical strategies, the risks of reoperation and postoperative complications can be effectively reduced, thereby improving patient outcomes.

    Key words: Thyroid; cancer,Primary; hyperparathyroidism, Surgical; Treatment,Disease; Characteristics,Diagnostic; Methods

    Submit time: 16 April 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • liujing, panyaweng, rengzheng. Progress in robotic thyroidectomy in the treatment of thyroid cancer. 2024. doi: 10.12201/bmr.202411.00030

    李威, Geng Zhong li, Angshaer·Sulaiman. Innovation and evolution of neural monitoring technology in endoscopic thyroid cancer surgery. 2024. doi: 10.12201/bmr.202411.00051

    ZhouMengqian, Tang Tong. Prediction of Lateral Cervical Lymph Node metastasis risk in Thyroid Cancer based on preoperative Lymph Node Ultrasonographic Characteristics. 2024. doi: 10.12201/bmr.202410.00035

    Shaohua. . 2025. doi: 10.12201/bmr.202502.00039

    Si chen, Lijie Wang. Primary rectal melanoma: a case report. 2023. doi: 10.12201/bmr.202310.00004

    WuJie, Zhou Zhen-gan, XiaMing, SUN Hong-jie, Zhou Kai, Zhang Ting-rong, Li Shao-shan. Advancements in Surgical Treatment Research for Pituitary Neuroendocrine Tumors. 2025. doi: 10.12201/bmr.202501.00074

    The comparison in therapeutic efficacy between modified outer sleeve catheter stripping surgery and intracavitary laser treatment for primary great saphenous varicose vein. 2025. doi: 10.12201/bmr.202507.00078

    SHANG Hongqing. Diagnosis and Treatment of a Thyroid Foreign Body: a Case Report and Literature Review. 2025. doi: 10.12201/bmr.202509.00009

    DuYuPeng, LinYan. Exploration of Diagnostic and Treatment Experience in Two Cases of Idiopathic Retroperitoneal Fibrosis. 2024. doi: 10.12201/bmr.202410.00077

    Bai Xiaolin, Zhang ZeQun. Syndrome Differentiation and Treatment of Thyroid Nodules Based on the Theory of Smooth Flow of Primordial True Qi in Five Zang-Organs. 2025. doi: 10.12201/bmr.202506.00063

  • ID Submit time Number Download
    1 2025-02-24

    10.12201/bmr.202504.00050V1

    Download
  • Public  Anonymous  To author only

Get Citation

[authors missed]. [title missed]. 2025. biomedRxiv.202504.00050

Article Metrics

  • Read: 379
  • Download: 3
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误